Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review

Yuka Fukunishi; Shintaro Yanazume; Chikako Nagata; Mika Mizuno; Shinichi Togami; Hiroaki Kobayashi

doi:10.7759/cureus.65415

journal article Jul 26, 2024

Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review

Yuka Fukunishi Shintaro Yanazume Chikako Nagata Mika Mizuno Shinichi Togami Hiroaki Kobayashi

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.65415

Topics

No keywords indexed for this article. Browse by subject →

References

23

[1]

Fagotti A, Ferrandina G, Vizzielli G, et al.. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome. Eur J Cancer. 2016, 59:22-33. 10.1016/j.ejca.2016.01.017 10.1016/j.ejca.2016.01.017

[2]

Pomel C, Provencher D, Dauplat J, et al.. Laparoscopic staging of early ovarian cancer. Gynecol Oncol. 1995, 58:301-6. 10.1006/gyno.1995.1234 10.1006/gyno.1995.1234

[3]

Decloedt J, Vergote I. Laparoscopy in gynaecologic oncology: a review. Crit Rev Oncol Hematol. 1999, 31:15-26. 10.1016/s1040-8428(99)00013-x 10.1016/s1040-8428(99)00013-x

[4]

Fagotti A, Fanfani F, Ludovisi M, Lo Voi R, Bifulco G, Testa AC, Scambia G. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol. 2005, 96:729-35. 10.1016/j.ygyno.2004.11.031 10.1016/j.ygyno.2004.11.031

[5]

Chéreau E, Ballester M, Selle F, Cortez A, Daraï E, Rouzier R. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. Am J Obstet Gynecol. 2010, 202:178.e1-8.e10. 10.1016/j.ajog.2009.10.856 10.1016/j.ajog.2009.10.856

[6]

Fagotti A, Vizzielli G, Fanfani F, et al.. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. Gynecol Oncol. 2013, 131:341-6. 10.1016/j.ygyno.2013.08.005 10.1016/j.ygyno.2013.08.005

[7]

Kehoe S, Hook J, Nankivell M, et al.. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet. 2015, 386:249-57. 10.1016/S0140-6736(14)62223-6 10.1016/s0140-6736(14)62223-6

[8]

Onda T, Satoh T, Saito T, et al.. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602. Eur J Cancer. 2016, 64:22-31. 10.1016/j.ejca.2016.05.017 10.1016/j.ejca.2016.05.017

[9]

Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol. 1998, 71:431-6. 10.1006/gyno.1998.5213 10.1006/gyno.1998.5213

[10]

Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer. 2006, 16 Suppl 1:35-40. 10.1111/j.1525-1438.2006.00323.x 10.1111/j.1525-1438.2006.00323.x

[11]

Angioli R, Palaia I, Zullo MA, Muzii L, Manci N, Calcagno M, Panici PB. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol. 2006, 100:455-61. 10.1016/j.ygyno.2005.09.060 10.1016/j.ygyno.2005.09.060

[12]

Fagotti A, Ferrandina G, Fanfani F, et al.. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol. 2008, 199:642.e1-6. 10.1016/j.ajog.2008.06.052 10.1016/j.ajog.2008.06.052

[13]

Brun JL, Rouzier R, Uzan S, Daraï E. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol. 2008, 110:354-9. 10.1016/j.ygyno.2008.04.042 10.1016/j.ygyno.2008.04.042

[14]

Varnoux C, Huchon C, Bats AS, Bensaid C, Achouri A, Nos C, Lécuru F. Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies. Eur J Surg Oncol. 2013, 39:774-9. 10.1016/j.ejso.2013.03.022 10.1016/j.ejso.2013.03.022

[15]

Petrillo M, Vizzielli G, Fanfani F, et al.. Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept. Gynecol Oncol. 2015, 139:5-9. 10.1016/j.ygyno.2015.07.095 10.1016/j.ygyno.2015.07.095

[16]

Dessapt AL, Huchon C, Ngo C, Bats AS, Bensaid C, Lecuru F. Is complete cytoreductive surgery feasible in this patient with ovarian cancer?. Surg Oncol. 2016, 25:326-31. 10.1016/j.suronc.2016.07.001 10.1016/j.suronc.2016.07.001

[17]

Eoh KJ, Yoon JW, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT. A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy. BMC Cancer. 2017, 17:481. 10.1186/s12885-017-3476-1 10.1186/s12885-017-3476-1

[18]

Vizzielli G, Costantini B, Tortorella L, et al.. A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: a single-institution assessment. Gynecol Oncol. 2016, 142:19-24. 10.1016/j.ygyno.2016.04.020 10.1016/j.ygyno.2016.04.020

[19]

Hansen JM, Sood AK, Coleman RL, et al.. Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer. Gynecol Oncol. 2018, 151:428-32. 10.1016/j.ygyno.2018.10.017 10.1016/j.ygyno.2018.10.017

[20]

Lee YJ, Chung YS, Lee JY, Nam EJ, Kim SW, Kim YT, Kim S. Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer. J Gynecol Oncol. 2023, 34:e17. 10.3802/jgo.2023.34.e17 10.3802/jgo.2023.34.e17

[21]

Rutten MJ, van Meurs HS, van de Vrie R, et al.. Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial. J Clin Oncol. 2017, 35:613-21. 10.1200/JCO.2016.69.2962 10.1200/jco.2016.69.2962

[22]

Rossetti D, Vitale SG, Gulino FA, et al.. Laparoendoscopic single-site surgery for the assessment of peritoneal carcinomatosis resectability in patients with advanced ovarian cancer. Eur J Gynaecol Oncol. 2016, 37:671-3.

[23]

Odajima S, Ueda K, Hosoya S, et al.. Clinical availability of tumour biopsy using diagnostic laparoscopy for advanced ovarian cancer. In Vivo. 2021, 35:3325-31. 10.21873/invivo.12629 10.21873/invivo.12629

Metrics

0

Citations

23

References

Details

Published: Jul 26, 2024

Authors

Cite This Article

Yuka Fukunishi, Shintaro Yanazume, Chikako Nagata, et al. (2024). Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review. Cureus. https://doi.org/10.7759/cureus.65415

Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review

You May Also Like